INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
![GettyImages-2185301590-microscope-scientist-lab]( "Matching Pharmacovigilance Methodology To Organizational Scale")
Matching Pharmacovigilance Methodology To Organizational ScaleOne-size-fits-all doesn't work for safety signal detection. Discover a scalable framework that keeps expert judgment at the center — no matter how large your portfolio grows.
-
![Machine Learning-AI-GettyImages-2236865789]( "Execution Intelligence: Get A Competitive Advantage In Clinical Trials")
Execution Intelligence: Get A Competitive Advantage In Clinical TrialsAI fails in clinical trials when decision-making is messy. To win, sponsors must fix their "execution blind spot" by structuring how work happens, letting AI turn hidden patterns into strategy.
-
![GettyImages-1363170011 health wearables]( "Achieving Data Compatibility And Navigating Hardware Evolution")
Achieving Data Compatibility And Navigating Hardware EvolutionSwitching wearable devices mid-study doesn't have to break your data. Learn how standardized methods keep long-term trials consistent and credible.
-
![GettyImages-1938555153 tablet, lab]( "Accelerating Study Startups: Drive Efficiency From Protocol To Go-Live")
Accelerating Study Startups: Drive Efficiency From Protocol To Go-LiveSpeed up trial launches and maintain predictable timelines by leveraging a modern, integrated approach to eCOA setup that reduces complexity.
-
Sustainable Clinical Trials Through eClinical Innovation8/26/2025
Clinical trials are essential to advancing medicine, yet they carry significant environmental costs. Inefficiencies not only drive emissions but also risk drug shortages and trial delays, and clinical technology solutions offer a pathway to more sustainable research.
-
Consolidating Access Into A Single Platform: A Site CEO's Perspective2/28/2025
By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.
-
Accelerating Clinical And Drug Development Timelines With AI5/8/2026
This presentation brings together perspectives from across the industry to explore how AI is being applied today to improve clinical project management and unlock new opportunities in drug discovery.
-
The Scoop On The SCOPE Summit2/19/2025
From industry partnerships to patient recruitment to proprietary data, SCOPE 2025 was packed with informational sessions.
-
Study Analysis – Site Payment Automation12/8/2025
By removing administrative bottlenecks, see how automation improves cash flow for sites, reduces operational burden for sponsors, and supports smoother, more predictable trial execution.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
![virtual-trials-televisits]( "TrialKit Engage For Televisits")
Conduct secure video based visits, manage study schedules, and keep participants connected through a single unified platform.
-
![GettyImages-1081869356 data]( "Comprehensive Data And Analytics For Cell, Gene, And RNA-Based Therapies")
Stay on top of changes in the ever-evolving world of cell and gene therapies and more. Our in-house subject matter experts comb through the data weekly to ensure we provide you with the most current and comprehensive information important to this market.
-
![Drug development iStock-1067499066]( "Drug Accountability And Returns Management")
See how sponsors are using electronic solutions for Drug Accountability (DA) and experiencing significant increases in efficiency and accuracy that these methods provide.
-
![Clinical Data]( "Synthetic Control Arm®: The Smart External Control Arm Solution")
Discover how an external control arm can help you generate rigorous evidence, accelerate decisions, and keep your trial on track when a concurrent control isn’t feasible.
-
![GettyImages-1468678613-doctor-setting-ipad-badge-hand]( "Patient Journey Insights Beyond The Clinical Trial Window")
This patient-level data linkage solution connects clinical trial data (CTD) with RWD, providing a continuous view of a patient’s health journey before, during, and after trial participation.
